These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 12203087)

  • 1. Single administration of ecabet sodium diminishes the level of delta-13CO2 in urea breath test.
    Ito M; Tanaka S; Yoshihara M; Chayama K; Haruma K
    J Gastroenterol; 2002; 37(8):674-5. PubMed ID: 12203087
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies?
    Gisbert JP; Olivares D; Jimenez I; Pajares JM
    Dig Liver Dis; 2006 Apr; 38(4):254-9. PubMed ID: 16309984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection.
    Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Fujioka T; Kodama M; Kagawa J
    J Gastroenterol; 2003; 38(10):937-41. PubMed ID: 14614600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New nondispersive infrared spectrometry in 13C-urea breath tests].
    Hartmann D; Schilling D; Riemann JF
    Dtsch Med Wochenschr; 2003 Aug; 128(31-32):1645-8. PubMed ID: 12894391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of the stable isotopes in life science (VI). 13CO2 analysis for the 13C-breath test].
    Suehiro M; Iio M
    Radioisotopes; 1982 Jun; 31(6):321-9. PubMed ID: 6817390
    [No Abstract]   [Full Text] [Related]  

  • 6. [The urea breath test].
    Filipec T; Katicić M; Papa B; Colić-Cvrlje V; Prskalo M; Tićak M; Sabarić B; Naumovski-Mihalić S; Skurla B
    Lijec Vjesn; 2002 Sep; 124 Suppl 1():28-33. PubMed ID: 12592813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus.
    Pearson JP; Roberts NB
    Clin Sci (Lond); 2001 Apr; 100(4):411-7. PubMed ID: 11256980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ecabet sodium, a locally acting antiulcer drug, inhibits urease activity of Helicobacter pylori.
    Ito Y; Shibata K; Hongo A; Kinoshita M
    Eur J Pharmacol; 1998 Mar; 345(2):193-8. PubMed ID: 9600637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ecabet sodium, an antiulcer drug, on gastric adaptive relaxation in isolated guinea-pig stomachs.
    Higuchi K; Tominaga K; Uno H; Yasuda M; Hashiume M; Matsumoto M; Watanabe T; Fujiwara Y; Oshitani N; Matsumoto T; Arakawa T
    Drugs Exp Clin Res; 2002; 28(2-3):105-11. PubMed ID: 12224376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable isotopes and 13CO2 breath tests for investigating gastrointestinal functions.
    Ghoos Y; Geypens B; Rutgeerts P
    Food Nutr Bull; 2002 Sep; 23(3 Suppl):166-8. PubMed ID: 12362787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The early effect of proton pump inhibitor therapy on the accuracy of the 13C-urea breath test.
    Mana F; Van Laer W; Bossuyt A; Urbain D
    Dig Liver Dis; 2005 Jan; 37(1):28-32. PubMed ID: 15702856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori eradication: how can I choose an appropriate therapy?
    Franceschi F; Gasbarrini A
    Dig Liver Dis; 2006 Apr; 38(4):259-61. PubMed ID: 16527554
    [No Abstract]   [Full Text] [Related]  

  • 13. Gastroscopic real-time 13C-urea breath test.
    Fruehauf H; Lindenmann NC; Volkart K; Bauerfeind P; Fried M
    Endoscopy; 2005 Jun; 37(6):527-31. PubMed ID: 15933924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of anti-urease action by the anti-ulcer drug ecabet sodium.
    Ito Y; Hongo A; Kinoshita M; Tamaki H
    Biol Pharm Bull; 1995 Jun; 18(6):850-3. PubMed ID: 7550119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic study of a neutral meal suitable for subjects undergoing 13CO2 breath tests.
    Jonderko K; Kasicka-Jonderko A; Kamińska M; Błońska-Fajfrowska B
    Med Sci Monit; 2008 Oct; 14(10):CR543-6. PubMed ID: 18830195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ecabet sodium, a novel gastroprotective agent, on mucin metabolism in rat gastric mucosa.
    Ichikawa T; Ishihara K; Hayashida H; Hiruma H; Saigenji K; Hotta K
    Dig Dis Sci; 2000 Mar; 45(3):606-13. PubMed ID: 10749340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecabet sodium prevents esophageal lesions induced by the reflux of gastric juice in rats.
    Okuyama K; Saito N; Kume E; Noto T; Nagasaki M
    Inflammopharmacology; 2007 Apr; 15(2):90-4. PubMed ID: 17450449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. II. Interaction with substrate protein.
    Ito Y; Onoda Y; Nakamura S; Tagawa K; Fukushima T; Sugawara Y; Takaiti O
    Jpn J Pharmacol; 1993 Jun; 62(2):175-81. PubMed ID: 8371516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. I. Inactivation of enzyme protein.
    Ito Y; Nakamura S; Onoda Y; Sugawara Y; Takaiti O
    Jpn J Pharmacol; 1993 Jun; 62(2):169-74. PubMed ID: 8371515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of 13C-labelled glycosyl ureides for evaluation of orocaecal transit time.
    Wutzke KD; Glasenapp B
    Eur J Clin Nutr; 2004 Apr; 58(4):568-72. PubMed ID: 15042123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.